Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10353)
All Articles published online
|
Publishing Process of This Article
|
Aug 18, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsiaoussis GI, Assimakopoulos SF, Tsamandas AC, Triantos CK, Thomopoulos KC. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications. World J Hepatol 2015; 7(17): 2058-2068 [PMID: 26301048 DOI: 10.4254/wjh.v7.i17.2058] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i17/2058.htm |
| Number | Citing Articles |
| 1 |
Juan Carlos Q. Velez, Nyan Latt, Roger A. Rodby. Pathophysiology of Hepatorenal Syndrome. Advances in Kidney Disease and Health 2024; 31(2): 87 doi: 10.1053/j.akdh.2024.01.002
|
| 2 |
Georgios I. Tsiaoussis, Eleni C. Papaioannou, Eleni P. Kourea, Stelios F. Assimakopoulos, Georgios I. Theocharis, Michalis Petropoulos, Vasileios I. Theopistos, Georgia G. Diamantopoulou, Zoi Lygerou, Iris Spiliopoulou, Konstantinos C. Thomopoulos. Expression of α-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function. Digestive Diseases and Sciences 2018; 63(10): 2582 doi: 10.1007/s10620-018-5146-9
|
| 3 |
Fernanda Raya Tonetti, Alvaro Eguileor, Cristina Llorente. Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases. eGastroenterology 2024; 2(3): e100098 doi: 10.1136/egastro-2024-100098
|
| 4 |
Jessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, Salvatore Piano, Alice Cheng, Aruna K. Subramanian, W. Ray Kim. Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda. Hepatology Communications 2024; 8(10) doi: 10.1097/HC9.0000000000000539
|
| 5 |
Arjun Kanwal, Navya Allugubelli, Jason Kaplan, Nargiz Muganlinskaya. E. coli endocarditis of the tricuspid valve. Journal of Community Hospital Internal Medicine Perspectives 2019; 9(6): 495 doi: 10.1080/20009666.2019.1684424
|
| 6 |
Mei Luo, Yuanhong Xu, Jike Li, Dongxia Luo, Li Zhu, Yanxi Wu, Xiaodong Liu, Pengfei Wu. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0714
|
| 7 |
Luca Maccioni, Yaojie Fu, Yves Horsmans, Isabelle Leclercq, Peter Stärkel, George Kunos, Bin Gao. Alcohol-associated bowel disease: new insights into pathogenesis. eGastroenterology 2023; 1(1): e100013 doi: 10.1136/egastro-2023-100013
|
| 8 |
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert Review of Gastroenterology & Hepatology 2023; 17(1): 31 doi: 10.1080/17474124.2023.2162503
|
| 9 |
Ali Sepehrinezhad, Ali Shahbazi. Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management. 2024; doi: 10.5772/intechopen.1004125
|
| 10 |
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249
|
| 11 |
Xianmei Wu, Junli Luo, Wenxiang Huang, Bei Jia, Tao Luo. Role of ascitic endocan levels in the diagnosis of spontaneous bacterial peritonitis in decompensated cirrhosis. Biomarkers 2020; 25(4): 360 doi: 10.1080/1354750X.2020.1764107
|
| 12 |
Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases. International Journal of Molecular Sciences 2023; 24(2): 1470 doi: 10.3390/ijms24021470
|
| 13 |
Maria-Eleni Roumelioti, Robert H Glew, Zeid J Khitan, Helbert Rondon-Berrios, Christos P Argyropoulos, Deepak Malhotra, Dominic S Raj, Emmanuel I Agaba, Mark Rohrscheib, Glen H Murata, Joseph I Shapiro, Antonios H Tzamaloukas. Fluid balance concepts in medicine: Principles and practice. World Journal of Nephrology 2018; 7(1): 1-28 doi: 10.5527/wjn.v7.i1.1
|
| 14 |
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022; 14(19): 4631 doi: 10.3390/cancers14194631
|
| 15 |
Guole Nie, Honglong Zhang, Danna Xie, Jun Yan, Xun Li. Liver cirrhosis and complications from the perspective of dysbiosis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1320015
|
| 16 |
B. Esnaola Iriarte, S. Telletxea Benguria, K. Intxaurraga Fernández, E. Díez Castillo. Endocarditis infecciosa sobre válvula nativa por Escherichia coli resistente a ampicilina en el postoperatorio de una nefrectomía radical derecha por pielonefritis xantogranulomatosa. Revista Española de Anestesiología y Reanimación 2020; 67(2): 103 doi: 10.1016/j.redar.2019.09.006
|
| 17 |
Jim Höppner, Sandra Krohn, Ellen H. A. van den Munckhof, René Kallies, Adam Herber, Katharina Zeller, Jan Tünnemann, Madlen Matz-Soja, Antonis Chatzinotas, Stephan Böhm, Albrecht Hoffmeister, Thomas Berg, Cornelius Engelmann. Changes of the bacterial composition in duodenal fluid from patients with liver cirrhosis and molecular bacterascites. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49505-3
|
| 18 |
Jennifer L Peng, Witina Techasatian, Takashi Hato, Suthat Liangpunsakul. Role of Endotoxemia in Causing Renal Dysfunction in Cirrhosis. Journal of Investigative Medicine 2020; 68(1): 26 doi: 10.1136/jim-2019-001056
|
| 19 |
Ding Shi, Longxian Lv, Daiqiong Fang, Wenrui Wu, Chenxia Hu, Lichen Xu, Yanfei Chen, Jing Guo, Xinjun Hu, Ang Li, Feifei Guo, Jianzhong Ye, Yating Li, Dewi Andayani, Lanjuan Li. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07091-1
|
| 20 |
Floriana Morgillo, Marcello Dallio, Carminia Maria Della Corte, Antonietta Gerarda Gravina, Giuseppe Viscardi, Carmelina Loguercio, Fortunato Ciardiello, Alessandro Federico. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota. Neoplasia 2018; 20(7): 721 doi: 10.1016/j.neo.2018.05.002
|
| 21 |
Valeria García-Castillo, Enrique Sanhueza, Eileen McNerney, Sergio A. Onate, Apolinaria García. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle.
Journal of Medical Microbiology
2016; 65(12): 1347 doi: 10.1099/jmm.0.000371
|
| 22 |
Marta Ramirez, Nuria Pell, Marc Mejias, Mercedes Fernandez. Pericyte Biology in Different Organs. Advances in Experimental Medicine and Biology 2019; 1122: 73 doi: 10.1007/978-3-030-11093-2_5
|
| 23 |
Stephanie A.K. Angarita, Sergio Duarte, Tara A. Russell, Piotr Ruchala, Irmina A. Elliott, Julian P. Whitelegge, Ali Zarrinpar. Quantitative Measure of Intestinal Permeability Using Blue Food Coloring. Journal of Surgical Research 2019; 233: 20 doi: 10.1016/j.jss.2018.07.005
|
| 24 |
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
|
| 25 |
Christos Triantos, Maria Kalafateli, Stelios F. Assimakopoulos, Katerina Karaivazoglou, Aikaterini Mantaka, Ioanna Aggeletopoulou, Panagiota I. Spantidea, Georgios Tsiaoussis, Maria Rodi, Hariklia Kranidioti, Dimitrios Goukos, Spilios Manolakopoulos, Charalambos Gogos, Dimitrios N. Samonakis, Georgios L. Daikos, Athanasia Mouzaki, Konstantinos Thomopoulos. Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.836306
|
| 26 |
Ana Luísa Santos, Rosa Coelho, Marco Silva, Rui Morais, Hélder Cardoso, Guilherme Macedo. A Predictive Model for Avoiding Follow-Up Paracentesis in Spontaneous Bacterial Peritonitis. GE - Portuguese Journal of Gastroenterology 2022; 29(6): 393 doi: 10.1159/000519934
|
| 27 |
Ali Shahbazi, Ali Sepehrinezhad, Edris Vahdani, Raika Jamali, Monireh Ghasempour, Shirin Massoudian, Sajad Sahab Negah, Fin Stolze Larsen. Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain. Biomedicines 2023; 11(5): 1272 doi: 10.3390/biomedicines11051272
|
| 28 |
Clémence Chevalier, Pascale Fouqueray, Sébastien Bolze. Imeglimin: A Clinical Pharmacology Review. Clinical Pharmacokinetics 2023; 62(10): 1393 doi: 10.1007/s40262-023-01301-y
|
| 29 |
Dinesh Kumar, Gaurav Pandey, Deepak Bansal, Atul Rawat, Umesh Kumar, Durgesh Dubey, Anupam Guleria, Vivek Anand Saraswat. NMR‐based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients. Magnetic Resonance in Chemistry 2017; 55(4): 289 doi: 10.1002/mrc.4525
|
| 30 |
Shaimaa R. Elkhateeb, Nawal S. Gouda, Ahmed S. Ibrahim, Rokiah Anwar, Laila A. Eissa. PCR-detected fungal infection is associated with fatal outcomes in cirrhotic patients with spontaneous peritonitis. Egyptian Journal of Basic and Applied Sciences 2017; 4(1): 42 doi: 10.1016/j.ejbas.2016.10.002
|
| 31 |
Mohammad Mehdi Ommati, Omid Farshad, Hossein Niknahad, Khadijeh Mousavi, Marjan Moein, Negar Azarpira, Hamidreza Mohammadi, Akram Jamshidzadeh, Reza Heidari. Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction. Current Research in Pharmacology and Drug Discovery 2020; 1: 10 doi: 10.1016/j.crphar.2020.06.001
|
| 32 |
B. Esnaola Iriarte, S. Telletxea Benguria, K. Intxaurraga Fernández, E. Díez Castillo. Native valve infective endocarditis due to ampicillin-resistant Escherichia coli in the postoperative period of a right radical nephrectomy due to xanthogranulomatous pyelonephritis. Revista Española de Anestesiología y Reanimación (English Edition) 2020; 67(2): 103 doi: 10.1016/j.redare.2019.09.005
|
| 33 |
Mohammad Mehdi Ommati, Omid Farshad, Khadijeh Mousavi, Akram Jamshidzadeh, Mohammadreza Azmoon, Sirus Heidari, Negar Azarpira, Hossein Niknahad, Reza Heidari. Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic rats. PharmaNutrition 2020; 12: 100179 doi: 10.1016/j.phanu.2020.100179
|
| 34 |
Siyuan Sun, Guangheng Zhang, Shimeng Lv, Jinhui Sun. Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1407991
|
| 35 |
Rebeca Pérez-Cabeza De Vaca, Balasubramaniyan Vairappan, Tomás Cortés Espinoza, Juan Antonio Suárez Cuenca, Cuauhtemoc Licona Cassani, Brenda Maldonado Arriaga, Chrisitan Navarro Gerrard, Diana Selene Morgan Penagos, Paul Mondragón Terán, Victoria Chagoya De Sanchez. Advances in Hepatology. 2021; doi: 10.5772/intechopen.96910
|
| 36 |
Audrey Lasry, Adar Zinger, Yinon Ben-Neriah. Inflammatory networks underlying colorectal cancer. Nature Immunology 2016; 17(3): 230 doi: 10.1038/ni.3384
|
| 37 |
Clémence Chevalier, Julie Dubourg, Sébastien Bolze, Pascale Fouqueray. Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment. Clinical Pharmacokinetics 2021; 60(4): 485 doi: 10.1007/s40262-020-00948-1
|
| 38 |
R. Martín-Mateos, B. Mateos, J.L. Lledó, L. Téllez, A. Albillos. Infecciones bacterianas en la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2016; 12(12): 666 doi: 10.1016/j.med.2016.05.020
|
| 39 |
Irina Balazs, Vanessa Stadlbauer. Circulating neutrophil anti-pathogen dysfunction in cirrhosis. JHEP Reports 2023; 5(11): 100871 doi: 10.1016/j.jhepr.2023.100871
|
| 40 |
Rolandas Gedgaudas, Jasmohan S Bajaj, Jurgita Skieceviciene, Greta Varkalaite, Gabija Jurkeviciute, Sigita Gelman, Irena Valantiene, Romanas Zykus, Andrius Pranculis, Corinna Bang, Andre Franke, Christoph Schramm, Juozas Kupcinskas. Circulating microbiome in patients with portal hypertension. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2029674
|
| 41 |
T. Krentz, S. Allen. Bacterial translocation in critical illness. Journal of Small Animal Practice 2017; 58(4): 191 doi: 10.1111/jsap.12626
|
| 42 |
Cyriac A. Philips, Philip Augustine. Gut Barrier and Microbiota in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(2): 625 doi: 10.1016/j.jceh.2021.08.027
|
| 43 |
Reza Heidari. Natural Molecules in Neuroprotection and Neurotoxicity. 2024; : 957 doi: 10.1016/B978-0-443-23763-8.00075-0
|
| 44 |
Stelios F. Assimakopoulos, Sanjay Bhagani, Ioanna Aggeletopoulou, Efthymios P. Tsounis, Emmanuel A. Tsochatzis. The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations. Infection 2024; 52(3): 723 doi: 10.1007/s15010-024-02182-4
|
| 45 |
Noha Ahmed Nasef, Sunali Mehta. Role of Inflammation in Pathophysiology of Colonic Disease: An Update. International Journal of Molecular Sciences 2020; 21(13): 4748 doi: 10.3390/ijms21134748
|
| 46 |
Nobuhiro Akuzawa, Masahiko Kurabayashi. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovascular Disorders 2018; 18(1) doi: 10.1186/s12872-018-0929-7
|
| 47 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 48 |
Yue Zhang, Pengfei Li, Bo Chen, Ruipeng Zheng. Therapeutic effects of fecal microbial transplantation on alcoholic liver injury in rat models. Clinics and Research in Hepatology and Gastroenterology 2024; 48(9): 102478 doi: 10.1016/j.clinre.2024.102478
|
| 49 |
Theodoros A Voulgaris, Dimitrios Karagiannakis, E Hadziyannis, Spilios Manolakopoulos, Georgios P Karamanolis, George Papatheodoridis, John Vlachogiannakos. Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. World Journal of Hepatology 2021; 13(10): 1394-1404 doi: 10.4254/wjh.v13.i10.1394
|
| 50 |
Jianfei Long, Jingru Gong, Han Zhu, Xiaolin Liu, Ling Li, Bicui Chen, Hongyan Ren, Chao Liu, Huiping Lu, Jiming Zhang, Bin Wang. Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1232180
|
| 51 |
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 2017; 37(7): 587 doi: 10.1007/s40261-017-0519-y
|
| 52 |
Nadya M. Morrow, Arianne Morissette, Erin E. Mulvihill. Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut. Peptides 2024; 176: 171200 doi: 10.1016/j.peptides.2024.171200
|
| 53 |
Matthew Stratton, Cara Capitena, Logan Christensen, Miguel Paciuc-Beja. Escherichia coliEyelid Abscess in a Patient with Alcoholic Cirrhosis. Case Reports in Ophthalmological Medicine 2015; 2015: 1 doi: 10.1155/2015/827609
|
| 54 |
Yeshimebet Kassa, Yihenew Million, Alemu Gedefie, Feleke Moges. Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review. Infection and Drug Resistance 2021; : 2571 doi: 10.2147/IDR.S305901
|
| 55 |
Dominic-Luc Webb. Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future. Best Practice & Research Clinical Gastroenterology 2019; : 101636 doi: 10.1016/j.bpg.2019.101636
|
| 56 |
C.-F. Lee, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, Y.-C. Chen, R.-S. Soong, T.-J. Wu, H.-S. Chou, K.-M. Chan, W.-C. Lee. Application of CD8+ Cells Count as a Guide of Immunosuppressive Regimen Introduction for Very Sick Patients Undergoing Liver Transplantation. Transplantation Proceedings 2016; 48(10): 3356 doi: 10.1016/j.transproceed.2016.09.038
|
| 57 |
Hongchen Zhang, Shanshan Hu, Dongchao Xu, Hongzhang Shen, Hangbin Jin, Jianfeng Yang, Xiaofeng Zhang. Risk Factors for Carbapenem Resistant Gram Negative Bacteria (CR-GNB) Carriage Upon Admission to the Gastroenterology Department in a Tertiary First Class Hospital of China: Development and Assessment of a New Predictive Nomogram. Infection and Drug Resistance 2022; : 7761 doi: 10.2147/IDR.S396596
|